The latest skin cancer and melanoma news
Allergic inflammation and experimental skin cancer risk
The link between inflammation and the risk of cancer is much studied currently. Inflammation originally…
Browsing: Melanoma and Skin Cancer
Practice-changing trial results for advanced melanoma skin cancer
Determining the optimal treatment sequence for patients with BRAF V600 mutant metastatic melanoma was the focus of…
Giving immunotherapy before targeted therapy improves survival in advanced melanoma
More people with advanced melanoma survive for two years or more when they receive a…
Combination immunotherapy improves survival for patients with asymptomatic melanoma brain metastases
Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread…
Individual donor strains do not show link between faecal microbe transplantation and successful melanoma immunotherapy
The mix of microbes in the gut can shape a person’s immune response. In immunotherapy…
Direct-to-consumer skin cancer detection apps are failing to detect life-threatening cancers, new study finds
A new study has found that a direct-to-consumer machine learning model for detecting skin cancers…
Non-melanoma skin cancers increased 30% over 15 years in Ontario, Canada
Non-melanoma basal and squamous cell skin cancers increased 30% in Ontario between 2003 and 2017,…
New portable device opens the way for at-home skin cancer treatment, pilot study suggests
A new prototype photodynamic therapy (PDT) device that can be used at home significantly reduces…
Research provides new insight into fundamental workings of the immune system in response to therapy to treat skin cancer
New research led by the University of Birmingham, UK, suggests that skin cancer patients could…
ESMO 2021: KEYNOTE-716 Study
Highlights on pembrolizumab in fully resected high-risk stage II melanoma: KEYNOTE-716 study